TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7957481

Group type: EXPERIMENTAL
Intervention: Active approach (aggressive rehabilitation program at CPRC, 4-week program of daily physical therapy, occupational therapy, behavioral modification, and counseling)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Passive approach (functional electric stimulation - FES)
Number of subjects: 0
Study: 2820672

Group type: EXPERIMENTAL
Intervention: Wheat fiber
Number of subjects: 30

Group type: COMPARATOR
Intervention: Laxative regime (sterculia, magnesium sulfate, mineral oil)
Number of subjects: 30
Study: 29728201

Group type: EXPERIMENTAL
Intervention: Overfeeding (weight gain) for 8 weeks (n=16)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Weight maintenance (control) for 8 weeks (n=10)
Number of subjects: 26
Study: 28420352

Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention (daily weight measurement using digital scale)
Number of subjects: 826
Study: 26200182

Group type: EXPERIMENTAL
Intervention: Gabapentin (600 mg preoperatively followed by 200 mg every 8 h for 2 days)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 197
Study: 24119686

Group type: EXPERIMENTAL
Intervention: Routine cardiac magnetic resonance (CMR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective cardiac magnetic resonance (CMR)
Number of subjects: 0
Study: 21309443

Group type: EXPERIMENTAL
Intervention: Patients with early vascular dementia (VD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy elderly controls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy young controls
Number of subjects: 0
Study: 18503806

Group type: EXPERIMENTAL
Intervention: Hold and relax stretching technique of the pectoralis major
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham technique
Number of subjects: 14
Study: 17196055

Group type: EXPERIMENTAL
Intervention: Olanzapine (14.7 mg/day)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Risperidone (3.9 mg/day)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Both olanzapine and risperidone
Number of subjects: 329
Study: 14514637

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 87
Study: 10893357

Group type: EXPERIMENTAL
Intervention: Nitric oxide inhalation (20 parts per million for 30 min at 12‐h intervals until extubation)
Number of subjects: 7
Study: 9042260

Group type: EXPERIMENTAL
Intervention: ML-1 standardized mistletoe extract, 1 ng ML-1/kg BW, twice a week for 3 months, starting on day 1 post surgery
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group without additional complementary treatment
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ML-1 standardized mistletoe extract
Number of subjects: 35
Study: 1580775

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressings
Number of subjects: 39

Group type: COMPARATOR
Intervention: Saline-gauze dressings
Number of subjects: 39
Study: 2578724

Group type: EXPERIMENTAL
Intervention: Nimodipine (120 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (dextran therapy alone)
Number of subjects: 60
Study: 30788835

Group type: EXPERIMENTAL
Intervention: Cisplatin plus doxorubicin (Group A)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Paclitaxel (Group B)
Number of subjects: 41
Study: 29922605

Group type: EXPERIMENTAL
Intervention: SRM‐IV vestibular function diagnosis and treatment system
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Conventional manual repositioning procedure
Number of subjects: 120

Group type: COMPARATOR
Intervention: Combination of treatment drugs (alprostadil and safflower injection) with acclimatization training
Number of subjects: 120
Study: 27487437

Group type: EXPERIMENTAL
Intervention: Qigong Yi Jinjing (QYJJ)
Number of subjects: 130
Study: 24725034

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Advanced Moist Wound Therapy (AMWT)
Number of subjects: 324
Study: 22170727

Group type: EXPERIMENTAL
Intervention: Rimonabant 20 mg/d
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 21200420

Group type: EXPERIMENTAL
Intervention: Miltefosine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sb(v)
Number of subjects: 90
Study: 17396118

Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) ferric gluconate for eight consecutive hemodialysis sessions spanning 6 weeks with epoetin increased by 25%
Number of subjects: 134

Group type: COMPARATOR
Intervention: No added iron with epoetin increased by 25%
Number of subjects: 134
Study: 15567810

Group type: EXPERIMENTAL
Intervention: midazolam 2 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: midazolam 5 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: midazolam 10 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: control (normal saline)
Number of subjects: 40
Study: 12079935

Group type: COMPARATOR
Intervention: 100 IU x kg(‐1) of heparin (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 150 IU x kg(‐1) of heparin (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 4F cannula
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Higher dose of heparin
Number of subjects: 60
Study: 10539232

Group type: EXPERIMENTAL
Intervention: Role model story newsletters mailed to parents (experimental group)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control condition (no newsletters)
Number of subjects: 77
Study: 7726462

Group type: EXPERIMENTAL
Intervention: Headgear
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Functional appliance
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control
Number of subjects: 94
Study: 2252526

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins (0.4 g/kg/BW) for 1 week and once per week for 6 months
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 7351109

Group type: EXPERIMENTAL
Intervention: Pentoxifylline with memory-aid stickers
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Pentoxifylline without memory-aid stickers
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (both groups)
Number of subjects: 179
Study: 29340869

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (10 Hz, n = 15)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (10 Hz)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham rTMS (n = 14)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Healthy participants (n = 26)
Number of subjects: 29
Study: 27121531

Group type: EXPERIMENTAL
Intervention: Baseline multivitamin users
Number of subjects: 18530

Group type: EXPERIMENTAL
Intervention: Self-reported duration of multivitamin use ≥20 years
Number of subjects: 18530

Group type: EXPERIMENTAL
Intervention: Baseline multivitamin use
Number of subjects: 18530
Study: 25786042

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 32
Study: 23024102

Group type: EXPERIMENTAL
Intervention: Oral chloral hydrate (100 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intranasal midazolam (0.2 mg/kg)
Number of subjects: 60
Study: 20630304

Group type: EXPERIMENTAL
Intervention: ProFile Series 29 to size #6 (#36/.06) at working length (WL)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: EndoSequence to #35/.06
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: ProFile Series 29 followed by LightSpeed in a hybrid technique to a final size #50
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: ProTaper and additional enlargement with LightSpeed to #50 in a hybrid technique
Number of subjects: 124
Study: 18374046

Group type: EXPERIMENTAL
Intervention: Beger procedure
Number of subjects: 65

Group type: COMPARATOR
Intervention: Berne modification
Number of subjects: 65
Study: 16771816

Group type: EXPERIMENTAL
Intervention: FTY720 5 mg plus RDC
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: FTY720 2.5 mg plus FDC
Number of subjects: 261

Group type: COMPARATOR
Intervention: MMF plus FDC
Number of subjects: 261
Study: 11580823

Group type: EXPERIMENTAL
Intervention: Electromyographic (EMG) biofeedback (BFB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Transcutaneous electrical neuromuscular stimulation (TENS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (BFB and TENS)
Number of subjects: 20
Study: 9847546

Group type: EXPERIMENTAL
Intervention: Auditory presentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Articulatory suppression
Number of subjects: 0
Study: 7994791

Group type: EXPERIMENTAL
Intervention: Adriamycin (ADM) 50 mg/50 ml saline
Number of subjects: 96

Group type: COMPARATOR
Intervention: Adriamycin (ADM) 50 mg/40 ml saline plus verapamil (VR) 25 mg/10 ml saline
Number of subjects: 96
Study: 2464184

Group type: EXPERIMENTAL
Intervention: Nonionic contrast media (iopromide, iopamidol, iohexol)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Blood-isotonic saline solution
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Nonionic contrast media followed by saline solution
Number of subjects: 94
Study: 7816385

Group type: EXPERIMENTAL
Intervention: Stannous enhancement method of preparation
Number of subjects: 38
Study: 378005

Group type: EXPERIMENTAL
Intervention: Intravenous cephalothin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Intravenous cefamandole
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Overall infection rate
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Frequency of anaerobic bacteremia
Number of subjects: 34
Study: 30199586

Group type: EXPERIMENTAL
Intervention: Tri tu 14
Number of subjects: 32
Study: 28285427

Group type: EXPERIMENTAL
Intervention: Intraoperative CO2 pressure of 15 mmHg
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Intraoperative CO2 pressure of 12 mmHg
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Intraoperative CO2 pressure of 10 or 8 mmHg
Number of subjects: 550
Study: 27707686

Group type: EXPERIMENTAL
Intervention: MMR+WEB (n=60)
Number of subjects: 109

Group type: COMPARATOR
Intervention: MMR (n=49)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: MMR+WEB and MMR
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: MMR+WEB
Number of subjects: 109
Study: 24449031

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 22674529

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (docetaxel 60 mg/m(2) and carboplatin AUC = 5 for 2 cycles) plus concurrent radiation therapy (40 Gy) followed by surgery (CRS arm)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Induction chemotherapy followed by surgery (CS arm)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: With downstaging
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Without downstaging
Number of subjects: 60
Study: 19948631

Group type: EXPERIMENTAL
Intervention: Apgar scores at 10 minutes
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Apgar scores of 0 at 10 minutes
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Apgar scores of 1 at 10 minutes
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Apgar scores of 2 at 10 minutes
Number of subjects: 188
Study: 18090460

Group type: EXPERIMENTAL
Intervention: Levetiracetam (500 to 3000 mg/d)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 14985605

Group type: EXPERIMENTAL
Intervention: Intervention group (lay delivered intervention by promotoras)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group (measurement only)
Number of subjects: 143
Study: 12608504

Group type: EXPERIMENTAL
Intervention: Trace metal supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary Reference Intakes for older adults
Number of subjects: 0
Study: 9807979

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg three times daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 7695971

Group type: EXPERIMENTAL
Intervention: OND 8 mg tablet
Number of subjects: 259

Group type: COMPARATOR
Intervention: ALI 150 mg i.v. injection followed by ALI 50 mg tablet
Number of subjects: 259
Study: 2623077

Group type: EXPERIMENTAL
Intervention: Cholecystokinin (CCK) 3 IDU/kg bodyweight
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Calcitonin (CT) 0.1 IU/kg bodyweight
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 340182

Group type: EXPERIMENTAL
Intervention: Diflunisal, 375 mg twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oxyphenbutazone, 200 mg twice daily
Number of subjects: 40
Study: 31550617

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) with the anode over the left posterior parietal cortex after reactivation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS) with the anode over the left posterior parietal cortex without reactivation
Number of subjects: 27

Group type: COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS) with the anode over a control site (primary visual cortex) after reactivation
Number of subjects: 27
Study: 27836220

Group type: EXPERIMENTAL
Intervention: Kinesiology tape (KT) applied to ankles
Number of subjects: 20
Study: 26163096

Group type: EXPERIMENTAL
Intervention: 12-month trastuzumab arm
Number of subjects: 3380

Group type: COMPARATOR
Intervention: 6-month trastuzumab arm
Number of subjects: 3380

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 3380
Study: 24127622

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 56
Study: 20370794

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg
Number of subjects: 134

Group type: COMPARATOR
Intervention: fluvastatin 80 mg XL
Number of subjects: 134
Study: 19690081

Group type: EXPERIMENTAL
Intervention: 0.1 mg NBI-6024
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: 0.5 mg NBI-6024
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: 1.0 mg NBI-6024
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: All groups (0.1 mg, 0.5 mg, 1.0 mg NBI-6024, and placebo)
Number of subjects: 188
Study: 17259154

Group type: EXPERIMENTAL
Intervention: Ulinastatin (UTI) 5000 U/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 40
Study: 15526248

Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 11474540

Group type: EXPERIMENTAL
Intervention: Vagal neurostimulation (VNS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (untreated CAD patients)
Number of subjects: 48
Study: 9506192

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (including long-acting dihydropyridines and nondihydropyridine agents)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-acting agents (e.g., nifedipine)
Number of subjects: 0
Study: 8036828

Group type: EXPERIMENTAL
Intervention: 10 micrograms yeast‐derived HBsAg
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: 20 micrograms yeast‐derived HBsAg
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: No medication at the time of vaccination
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Use of medication at the time of vaccination
Number of subjects: 112
Study: 3053313

Group type: EXPERIMENTAL
Intervention: Acarbose (BAY g 5421)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29501740

Group type: EXPERIMENTAL
Intervention: Healthy Lifestyles intervention
Number of subjects: 553

Group type: COMPARATOR
Intervention: Healthy Finances (attention control)
Number of subjects: 553
Study: 27259675

Group type: EXPERIMENTAL
Intervention: Unprotected intercourse
Number of subjects: 33

Group type: COMPARATOR
Intervention: Vaginal inoculation with male partner's semen
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sampling frequency and home versus clinic sampling
Number of subjects: 33
Study: 25714127

Group type: EXPERIMENTAL
Intervention: Respecting the Circle of Life (RCL) intervention
Number of subjects: 267

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 267
Study: 23445320

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg·kg(‐1))
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bupivacaine (2 mg·kg(‐1))
Number of subjects: 50
Study: 20130841

Group type: EXPERIMENTAL
Intervention: pioglitazone (15-30 mg/day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: metformin (500-750 mg/day)
Number of subjects: 55
Study: 18070142

Group type: EXPERIMENTAL
Intervention: Nitroglycerine infusion
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sublingual nifedipine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both groups (Nitroglycerine and Nifedipine)
Number of subjects: 32
Study: 15995024

Group type: EXPERIMENTAL
Intervention: 1 g/kg IVIG over 2 days
Number of subjects: 95

Group type: COMPARATOR
Intervention: 0.4 g/kg IVIG over 5 days
Number of subjects: 95

Group type: COMPARATOR
Intervention: 2 g/kg IVIG administered over 2 days
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 5 days treatment
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 2-day regimen
Number of subjects: 95
Study: 12850889

Group type: EXPERIMENTAL
Intervention: Test drink with antioxidants (450 ml/day for 4 weeks)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo drink (450 ml/day for 4 weeks)
Number of subjects: 98
Study: 10566127

Group type: EXPERIMENTAL
Intervention: HemoCue B-glucose
Number of subjects: 46

Group type: COMPARATOR
Intervention: Glucometer IV (Bayer), Glucotrend (Roche Diagnostics), One touch (Life Scan, Johnson & Johnson)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Different glucose meters
Number of subjects: 46

Group type: COMPARATOR
Intervention: Glucose meters in clinical departments
Number of subjects: 46
Study: 9235072

Group type: EXPERIMENTAL
Intervention: Weight loss and exercise intervention (12 weekly group sessions, 1 individual counseling session, 6 biweekly follow-up sessions)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Weight loss and exercise intervention
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (1 class on metabolic control and 2 mailings of nutrition information)
Number of subjects: 64
Study: 1662884

Group type: EXPERIMENTAL
Intervention: Temafloxacin 400 mg b.i.d. for 28 days
Number of subjects: 112
Study: 7068294

Group type: EXPERIMENTAL
Intervention: Static strength training program with 90% of the maximal static strength, 9 weeks, three times a week
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study: 31358540

Group type: EXPERIMENTAL
Intervention: Atezolizumab 0.1 to 20 mg/kg or ≥10 mg/kg every 3 weeks
Number of subjects: 45
Study: 30238189

Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept (IVA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All groups (IVTA, IVR, IVA)
Number of subjects: 100
Study: 26842262

Group type: EXPERIMENTAL
Intervention: Binge drinkers
Number of subjects: 42

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 42
Study: 24532394

Group type: EXPERIMENTAL
Intervention: Self-affirmation intervention
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 112
Study: 23351178

Group type: EXPERIMENTAL
Intervention: Mechanical chest compressions with the LUCAS™ device
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Conventional manual cardiopulmonary resuscitation (CPR)
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Post mortem examinations in 300 patients
Number of subjects: 2500
Study: 20800887

Group type: EXPERIMENTAL
Intervention: Circular muscle exercises
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 731
Study: 17392697

Group type: EXPERIMENTAL
Intervention: Low‐fat (15% fat), high‐fiber (18 g/1000 kcal) diet supplemented with 40 g soy protein isolate (n=26)
Number of subjects: 40

Group type: COMPARATOR
Intervention: USDA recommended diet (n=14)
Number of subjects: 40
Study: 16908468

Group type: EXPERIMENTAL
Intervention: Maladaptive coping strategies
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Psychological quality of life (QOL)
Number of subjects: 85
Study: 12651636

Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH) combined with artificial blood substitutes (ABS)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Isovolemic replacement of blood loss with colloid
Number of subjects: 204
Study: 10804328

Group type: EXPERIMENTAL
Intervention: 20% Intralipid (60 ml/h) and heparin (900 U/h) for 5.5 h
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 9
Study: 8778696

Group type: EXPERIMENTAL
Intervention: Inoue balloon catheter
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard balloon catheter
Number of subjects: 31
Study: 8065177

Group type: EXPERIMENTAL
Intervention: Serum prealbumin in patients with acute viral hepatitis
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Serum prealbumin in patients with chronic active hepatitis
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Serum prealbumin in patients with cirrhosis
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Serum prealbumin in patients with hepatoma
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Serum albumin in patients with acute viral hepatitis
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Serum albumin in patients with chronic liver diseases
Number of subjects: 78

Group type: COMPARATOR
Intervention: Serum prealbumin in normal subjects
Number of subjects: 78
Study: 3716785

Group type: EXPERIMENTAL
Intervention: Vacuum Extraction (VE)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Forceps
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (spontaneous delivery)
Number of subjects: 47